Guttmacher syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2957OMIM:176305Q87.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Guttmacher syndrome is an extremely rare autosomal dominant genetic disorder characterized by a distinctive combination of postaxial limb anomalies and genital malformations. The condition was first described by Guttmacher in 1993 in a large family spanning multiple generations. Key clinical features include postaxial polydactyly of the hands (extra digits on the ulnar side), second and third toe syndactyly (webbing between toes), and fifth finger clinobrachydactyly (short, curved little fingers). Genital anomalies are also a hallmark of the syndrome and may include hypospadias in males and uterine anomalies in females. The skeletal system and urogenital system are the primary body systems affected. The genetic basis of Guttmacher syndrome has been linked to mutations in the HOXA13 gene, which plays a critical role in limb and urogenital development. Mutations in this same gene are also responsible for hand-foot-genital syndrome, and Guttmacher syndrome is considered by some experts to be an allelic variant or a closely related condition within the HOXA13-related spectrum of disorders. The phenotypic overlap between these conditions includes distal limb malformations and genitourinary anomalies, though Guttmacher syndrome is distinguished by the presence of postaxial polydactyly. There is no specific cure or targeted therapy for Guttmacher syndrome. Management is symptomatic and supportive, typically involving orthopedic or surgical intervention for polydactyly and syndactyly when functionally or cosmetically indicated. Urogenital anomalies such as hypospadias may also require surgical correction. Genetic counseling is recommended for affected families given the autosomal dominant inheritance pattern. Long-term prognosis is generally favorable, as the condition does not typically affect lifespan or cognitive development.

Also known as:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Guttmacher syndrome.

View clinical trials →

No actively recruiting trials found for Guttmacher syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Guttmacher syndrome community →

No specialists are currently listed for Guttmacher syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Guttmacher syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Guttmacher syndromeForum →

No community posts yet. Be the first to share your experience with Guttmacher syndrome.

Start the conversation →

Latest news about Guttmacher syndrome

No recent news articles for Guttmacher syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Guttmacher syndrome

What is Guttmacher syndrome?

Guttmacher syndrome is an extremely rare autosomal dominant genetic disorder characterized by a distinctive combination of postaxial limb anomalies and genital malformations. The condition was first described by Guttmacher in 1993 in a large family spanning multiple generations. Key clinical features include postaxial polydactyly of the hands (extra digits on the ulnar side), second and third toe syndactyly (webbing between toes), and fifth finger clinobrachydactyly (short, curved little fingers). Genital anomalies are also a hallmark of the syndrome and may include hypospadias in males and ut

How is Guttmacher syndrome inherited?

Guttmacher syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Guttmacher syndrome typically begin?

Typical onset of Guttmacher syndrome is neonatal. Age of onset can vary across affected individuals.